Tele-CBT Following Bariatric Surgery: Randomized Control Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03315247 |
Recruitment Status :
Active, not recruiting
First Posted : October 20, 2017
Last Update Posted : May 18, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Behavioral: Telephone-Based CBT | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 350 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Randomized Control Trial |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Telephone-Based Cognitive Behavioural Therapy for Post-Operative Bariatric Surgery Patients: A Randomized Controlled Trial |
Actual Study Start Date : | February 9, 2018 |
Estimated Primary Completion Date : | December 2023 |
Estimated Study Completion Date : | December 2023 |

Arm | Intervention/treatment |
---|---|
No Intervention: Treatment as Usual
Participants assigned to the Treatment as Usual group will attend routine clinic visits at the Toronto Western Hospital Bariatrics Surgery Program (TWH-BSP). These visits generally include education on bariatric surgery and nutrition. Patients meet with select members of the multidisciplinary team at 1, 2, and 3 years post-surgery, and may attend an optional monthly support group. Participants' service utilization (i.e., attendance at optional sessions) will be documented and compared across groups.
|
|
Experimental: Telephone-Based CBT
The Tele-CBT intervention will be delivered 1 year following bariatric surgery. Participants will receive 6 weekly Telephone-based Cognitive Behavioural Therapy sessions and 1 final "booster" session 1 month later, all approximately 55-minutes in duration and scheduled at a time convenient for the participants.
|
Behavioral: Telephone-Based CBT
The Tele-CBT sessions focus on introducing the cognitive behavioural model of overeating and obesity, scheduling healthy meals and snacks at regular time intervals and recording consumption using food records, scheduling pleasurable alternative activities to overeating, identifying and planning for difficult eating scenarios, and reducing vulnerability to overeating by solving problems and challenging negative thoughts. Participants are expected to complete CBT homework between sessions, such as completing food records, engaging in pleasurable and self-care activities, and completing a variety of worksheets.
Other Name: Tele-CBT |
- Change in Weight [ Time Frame: 1.25, 1.5, 2, 3 years post-surgery ]Change in weight measured in kg
- Changes in obesity-related medical comorbidities - Medication Burden [ Time Frame: 2 and 3 years post-surgery ]Medication pill burden/Type 2 Diabetes Mellitus (T2DM) specific medication burden
- Changes in obesity-related medical comorbidities - Medical Treatments [ Time Frame: 2 and 3 years post-surgery ]Discontinuation of medical treatments
- Changes in obesity-related medical comorbidities - T2DM [ Time Frame: 2 and 3 years post-surgery ]Remission of T2DM (normalization of lab values discontinuation of medical treatments and remission of T2DM/normalization of lab values)
- Changes in eating pathology - Emotional Eating [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the Emotional Eating Scale (EES). The EES is a 25-item self-report measure that assesses the tendency to cope with negative affect by eating. Respondents are presented with 25 emotions and are asked to rate the strength of their urge to eat on a scale from 1 (no desire to eat) to 5 (an overwhelming urge to eat) when experiencing each of the emotions. The total EES score is calculated as a sum of all 25 self-report answers. The EES consists of 3 subscales reflecting anger/frustration, anxiety, and depression. The EES subscale scores are calculated as a sum of all self-report answers of emotions that fall within the subscale categories.
- Changes in eating pathology - Binge Eating [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the Binge Eating Scale (BES). The BES is a 16-item self-report measure that assesses the presence of binge eating behaviour indicative of an eating disorder. It was devised specifically for use with obese individuals. Respondents are asked to rate the way they feel about their eating behaviour from 1 (statements indicating they see no problem with their eating behaviour) to 4 (statements indicating they see a severe problem with their eating behaviour). Scores on the BES range from 0 to 46 with the total score calculated as a sum of all 16 self-report answers. Moderate and severe levels of binge eating correspond to cut-off scores of 18 and 27.
- Changes in eating pathology - Loss of Control [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the Loss of Control over Eating Scale (LOCES-Brief). The LOCES-Brief is a 7-item self-report measure that assesses the behavioural and cognitive aspects of loss of control eating, which may occur even in the absence of objectively large eating binges. Respondents are asked to rate the frequency with which they have experienced loss of control over eating over the last month on a scale ranging from 1 (never) to 5 (always). Scores on the LOCES-Brief can range from 7 to 35 with the total score calculated as a sum of all 7 self-report answers.
- Changes in eating pathology - Depression [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the Patient Health Questionnaire (PHQ-9). The PHQ-9 is a 9-item self-report measure of depression severity. Respondents are asked to rate the frequency with which they have experienced depressive symptoms over the last two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day). Scores on the PHQ-9 can range from 0 to 27 with the total score calculated as a sum of all 9 self-report answers. Mild, moderate, moderately severe, and severe levels of depressive symptoms correspond to cut-off scores of 5, 10, 15, and 20 respectively.
- Changes in eating pathology - Quality of Life [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the EuroQol (EQ-5D-5L). The EQ-5D-5L is a 25 item self-report measure of health-related quality of life. The EQ-5D-5L covers the 5 domains of mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Each domain consists of 5 statements ranging from "I have no problems" to "I am unable to/I have extreme problems". Respondents are also asked to rate how good or bad their health is at the current point in time on a scale from 0 (worst health you can imagine) to 100 (best health you can imagine).
- Changes in eating pathology - Anxiety [ Time Frame: 1.25, 1.5, 2, and 3 years post-surgery ]Measured by the Generalized Anxiety Disorder Scale (GAD-7). The GAD-7 is a 7-item self report measure of anxiety severity. It was originally developed to diagnose generalized anxiety disorder, but it has also proved to be a good screening instrument for other disorders including panic disorder, social phobia, and post-traumatic stress disorder. Respondents are asked to rate the frequency with which they have experienced anxiety symptoms over the last two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day). Scores on the GAD-7 can range from 0 to 21 with the total score calculated as a sum of all 7 self-report answers. Mild, moderate, and severe levels of anxiety symptoms correspond to cut-off scores on 5, 10, and 15 respectively.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Received bariatric surgery 1 year ago
- Fluent in English
- Have Internet access to complete online questionnaires.
Exclusion Criteria:
- Current active suicidal ideation
- Current poorly controlled psychiatric illness that would render Tele-CBT very difficult, including serious mental illness (i.e., psychotic disorder, bipolar disorder), severe depression (i.e., current major depressive episode diagnosis and Patient Health Questionnaire [PHQ-9]61 score > 20), or severe anxiety (i.e., current anxiety disorder diagnosis and Generalized Anxiety Disorder [GAD-7]62 score >15)
- Current poorly controlled medical illness that would render Tele-CBT very difficult.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03315247
Canada, Ontario | |
Toronto Western Hospital | |
Toronto, Ontario, Canada, M5T2S8 |
Principal Investigator: | Sanjeev Sockalingam, MD, FRCPC | University of Toronto, University Health Network | |
Principal Investigator: | Stephanie Cassin, PhD, CPsych | Toronto Metropolitan University | |
Study Director: | Raed Hawa, MD, FRCPC | University of Toronto, University Health Network | |
Study Director: | Susan Wnuk, PhD, CPsych | University of Toronto, University Health Network | |
Study Director: | Timothy Jackson, MD, FRCPC | University of Toronto, University Health Network | |
Study Director: | Lorraine Lipscombe, MD, FRCPC | Women's College Hospital | |
Study Director: | Allan Okrainec, MD, FRCPC | University of Toronto, University Health Network | |
Study Director: | George Tomlinson, PhD | University of Toronto | |
Study Director: | David Urbach, MD, FRCPC | University of Toronto, University Health Network |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Sanjeev Sockalingam, Deputy Psychiatrist-in-Chief, University Health Network, Toronto |
ClinicalTrials.gov Identifier: | NCT03315247 |
Other Study ID Numbers: |
17-5655 376045 ( Other Grant/Funding Number: Canadian Institutes of Health Research (CIHR) ) |
First Posted: | October 20, 2017 Key Record Dates |
Last Update Posted: | May 18, 2022 |
Last Verified: | May 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Individual participant data (IPD) will not be shared publicly in order to protect patient confidentiality. Aggregate and anonymous data will be shared in peer reviewed journal articles and scientific presentations. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Obesity Bariatric Surgery Bariatrics Cognitive Therapy Binge Eating |
Obesity Overweight Overnutrition Nutrition Disorders Body Weight |